2024-515751-38-00招募中1 期
Safety, Tolerability and Pharmacokinetic Profile of TPT0301 in Healthy Volunteers
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Kirsten Harting
Scientific
Tetra Pharm Technologies ApS
研究点 (1)
Loading locations...
相似试验
尚未招募
1 期
Phase 1a study of VGA039 in healthy volunteers and patients with von Willebrand diseaseCTRI/2024/04/065934Vega Therapeutics, Inc
招募中
不适用
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of single and multiple escalating doses of ODM-111 and effect of food on the pharmacokinetics of ODM-111 and pharmacokinetic drug-drug interaction potential of ODM-111Chronic-/neuropathic pain10029305NL-OMON53911Orion Corporation182
进行中（未招募）
1 期
A study on the safety and effectiveness of the new investigational drug ODM-111 when given to healthy volunteers, and how ODM-111 is absorbed and processed by the human body.ovel treatment against chronic-/neuropathic pain.Nervous System DiseasesISRCTN84512888Orion Corporation (Finland)148
已完成
不适用
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of single and multiple escalating doses of ODM-108: a single centre study in healthy male volunteers.europathische pijn.Nerve damage pain.NL-OMON42514Orion Corporation Orion Pharma206
已完成
不适用
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCjRCT2031200362Amgen K.K.212